9/18/2020 3:10:07 AM
Regeneron Pharma, Sanofi Announce Presentation Of Positive Pivotal Data For Libtayo Monotherapy At ESMO
9/14/2020 7:05:43 AM
Regeneron Pharma And University Of Oxford To Evaluate Regeneron's Investigational Antibody Cocktail REGN-COV2 In The UK
9/14/2020 1:03:08 AM
Regeneron And Sanofi: FDA Grants Breakthrough Therapy Designation To Dupixent For Eosinophilic Esophagitis
9/8/2020 1:00:51 AM
Regeneron Pharma And Sanofi Announce New Results From Dupixent Phase 3 Open-label Extension Trial
8/19/2020 1:02:41 AM
Regeneron, Roche Collaborate To Increase Global Supply Of REGN-COV2 Investigational Antibody Cocktail For COVID-19
8/12/2020 7:08:09 AM
Regeneron Says FDA Accepted For Priority Review A BLA For Evinacumab
8/7/2020 4:27:59 PM
Regeneron Announces Pricing Of Public Offering Of Senior Unsecured Notes
8/5/2020 6:35:17 AM
Regeneron Pharma Q2 Revenues Increase 24% To $1.95 Bln
7/29/2020 7:06:41 AM
Regeneron Says BARDA Procures REGN-EB3 Investigational Ebola Treatment For National Preparedness
7/7/2020 7:04:45 AM
Regeneron Enters Manufacturing, Supply Agreement For BARDA And US DoD For REGN-COV2 Anti-Viral Antibody Cocktail